O

OXMAN

Computational design for biomaterials, architecture

Plant Synthetic Biologist

Full-Time
$116k - $145k/yr
Mid
PhD
New York, NY, USA
In Person
Biology & BiotechTranslational Research & Bench Biology

About the job

Requirements
  • A PhD or equivalent, with a focus on bioengineering or synthetic biology and its applications in the plant kingdom.
  • At least three years of industry or academic experience in plant biology research, genetic engineering, and/or application research and development for synthetic biology systems.
  • A portfolio of highly successful scientific or engineering work demonstrating out-of-the-box thinking and strong aesthetic judgment.
  • Fluency in relevant synthetic biology tools, including equipment and methods for plant growth, tissue culture, and regeneration; sequence design software; and transformation and cloning.
  • Ability to thrive in a self-directed environment.
  • Project management skills, organizational skills, and attention to detail.
  • Commitment to the team and the ability to maintain positive working relationships with diverse internal and external partners.
  • Ethics and integrity in all work, including scientific integrity and compliance with company and broader community policies.
Responsibilities
  • Lead plant biology projects across all stages, from concept development to product fruition.
  • Design and execute experiments that develop, validate, and/or enable novel products and processes leveraging synthetic biology.
  • Maintain high-quality documentation of scientific output and research through written reports, electronic lab notebooks, internal databases, code comments, and other records.
  • Nurture and augment OXMAN's scientific vision, uphold core design principles, and ensure high-quality, innovative work.
  • Partner with a multidisciplinary team of biologists, engineers, and designers across scientific and design pursuits.
  • Communicate ideas, work, and progress clearly through team meetings, presentations, and other creative communication outlets.

About the company

OXMAN designs and builds products, architecture, and molecular systems by blending computational design, materials science, robotics, biology, and ecological engineering. It follows Material Ecology, treating man-made objects as part of the environment and prioritizing growth and decay over traditional assembly and disposal. The firm works on product design, architectural design, and molecular design, collaborating with partners to apply nature-inspired principles, from biodegradable products like the O-zero shoe to carbon-sequestering buildings. Its cross-disciplinary, bio-informed workflow aims at ecological restoration and circular economy, funded by founder Neri Oxman and partners, with the goal of reducing waste, capturing carbon, and healing ecosystems.

Company Size

11-50

Company Stage

N/A

Total Funding

N/A

Headquarters

City of Watervliet, New York

Founded

2020

Get referred to OXMAN

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • In July 2026, OXMAN advanced bacterial textile coloration, expanding beyond footwear.
  • In August 2026, Ackman and Oxman committed $400 million to AOI, reinforcing founder wealth.
  • Goodman partnership gives OXMAN a large construction channel for ecological building methods.

What critics are saying

  • OXMAN still lacks visible mass-market revenue by September 2026.
  • Bill Ackman funds the company; any capital or reputation shock hits runway immediately.
  • The 2024 plagiarism fight keeps Neri Oxman exposed to recurring media and legal damage.

What makes OXMAN unique

  • OXMAN combines robotics, wet labs, and computational design in one New York campus.
  • Its Material Ecology thesis turns biodegradation into product architecture, not afterthought.
  • The O° platform uses single-material, zero-microplastic manufacturing across shoes and textiles.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Hybrid Work Options
  • Performance Bonus
  • Company Equity